ࡱ> '` 9bjbj{P{P t::F0.dddx***8*+|x,,(D,D,D,000  Ta| | Y$xh}d3C0033}D,D,}7}7}73D,dD, }73 }7}7.6dD,, b*4n 0cbe5b&bd?0o1h}71T+2000}}7^0003333xxxd!)xxx)xxx UNITED STATES MARINE CORPS Field Medical Training Battalion East Camp Lejeune FMST 1413 Manage Biological Agent Casualties TERMINAL LEARNING OBJECTIVE Given a biological warfare agent casualty in a combat environment and standard field medical equipment and supplies, manage biological casualties to prevent further injury or death. (FMST-HSS-1413) ENABLING LEARNING OBJECTIVES Without the aid of references, given a description or title, identify the general groups of biological agents, within 80% accuracy, per Medical Management of Biological Casualties, July 2000. (FMST-HSS-1413a) Without the aid of reference, given a description or list, identify the characteristics of various biological agents, within 80% accuracy, per Medical Management of Biological Casualties, July 2000. (FMST-HSS-1413b) Without the aid of references, given a description or list, identify symptoms of exposure of various biological agents, within 80% accuracy, per Medical Management of Biological Casualties, July 2000. (FMST-HSS-1413c) Without the aid of references, given a description or list, identify treatments for various biological agents, within 80% accuracy, per Medical Management of Biological Casualties, July 2000. (FMST-HSS-1413d) Without the aid of references, given a description or list, identify the four (4) phases of defensive measures against biological agents, within 80% accuracy, per Medical Management of Biological Casualties, July 2000. (FMST-HSS-1413e) HISTORY OF BIOLOGICAL WARFARE At the end of World War II, the Imperial Japanese army initiated an aggressive research effort to produce an effective biological agent. The goal was to learn the medical effects of such agents and determine the different methods of delivery. The most recent indication of offensive biological warfare capability comes from Team Seven of the United Nations Special Commission, which conducted inspections of Iraqi biological warfare research and development. The Iraqi government announced that prior to Operation Desert Storm, research had been conducted into the use of Bacillus Anthracis, Botulinum toxins, and Clostridium perfringens. BIOLOGICAL WARFARE Definition: The intentional use of living infectious microrganisms or toxins, derived from living organisms, to cause death or disease in humans, animals or plants. Delivery may be in the form of sprays, explosive devices (i.e. cluster bombs, or warheads) and contaminated food /water supplies. The most common method is aerosolizing the agent in a spray (i.e crop dusting). Signs and symptoms of biological agents will initially mirror the signs and symptoms of naturally occurring diseases making exposure difficult to diagnose. Laboratory analysis is the only definate way to confirm biological agent exposure. General Groups of Biological Agents Bacteria - free living microorganisms that are naturally occurring or engineered. They work by overcoming the body's defense mechanism by invading cells. Most are killed by antibiotics. Examples: Anthrax Plague Brucellosis Virus - an infectious agent, smaller than bacteria, that lacks independent metabolism and is able to replicate only within a host cell. Viruses produce diseases that do not respond to antibiotics. Supportive care is the only treatment. Examples: Smallpox Venezuelan Equine Encephallitis (VEE) Viral Hemorrhagic Fever (VHF) Biological Toxins - toxins are poisons which are produced by functions of microorganisms, plants and animals. Toxins do not grow or replicate, but have been classified biological agents by the United States due to their ability to be biochemically engineered. Examples: Botulism Ricin Mycotoxins Staphylococcal enterotoxin B CHARACTERISTICS OF BIOLOGICAL AGENTS Bacterial Agents Anthrax (Bacillus anthracis) - an acute bacterial infection of the skin, lungs or gastrointestinal tract. Anthrax is endemic worldwide. Anthrax was weaponized in 1950. Causes of Anthrax - Primarily a disease of herbivorous animals. Cattle, sheep and horses are the most common domesticated animal hosts. - Cutaneous infection occurs when handling infected animal tissue, contaminated hair, wool, hides or products made from infected slaughtered animals. - Respiratory infection results from inhaling anthrax spores. - Intestinal infection results from ingesting infected meat. Signs and Symptoms of Anthrax: Signs usually present within 48 hours. The incubation period for anthrax is hours to 7 days. Cutaneous: on the skin - Begins as a papule followed by the formation of a fluid filled vesicle - Normally appears on hands and forearms first - The vesicle typically dries and forms a coal-black scab. This scab is usually surrounded by mild to moderate edema (sometimes with small secondary vesicles). - Pain is unusual, and if present, is caused by secondary infection Inhalation: in the lungs - Gradual and nonspecific onset of fever, malase, fatigue, nonproductive cough and mild chest discomfort - Initial symptoms are followed by a short period of improvement (hours to 2-3 days) - Abrupt onset of severe repiratory distress with dyspnea, diaphoresis, stridor and cyanosis - Septicemia, shock and death usually follow within 24-36 hours after onset of respiratory distress Gastrointestinal: in the intestines - Presents with severe sore throat or a local oral or tonsillar ulcer - Nonspecific symptoms of nausea, vomiting and fever - Followed by severe abdominal pain with hematemesis and diarrhea Treatment for Anthrax: - Ciprofloxacin 400mg IV every 8-12 hours or 500mg by mouth twice daily for four weeks - Employ standard precautions for handling, treating, and moving all active cases Prevention - Prophylactic vaccination series Plague - caused by the bacterium Yersinia pestis which naturally infects rodents in certain parts of the world. There are three main types of plague: Bubonic, Pneumonic and Septicemic. Causes of Plague - The primary mode of transmission is flea bites - A secondary source of infection is through aerosolized droplets of sputum from an infected person Signs and Symptoms of Plague Bubonic - Acute onset fever, malaise, headache, nausea/vomiting - Swollen lymph nodes in the groin or axilla region - May have lesion at flea bite site - Bubonic plague may progress spontaneously to the septicemic form with organisms spreading to the lungs and producing pneumonic disease Pneumonic Acute onset of fever, chills and malaise Hemoptysis Nausea/vomiting/diarrhea and abdominal pain Dyspnea, stridor and cyanosis Death is caused by respiratory failure and circulatory collapse Almost always fatal if not treated within 24 hours Septicemic Plague - Fever, chills, malaise, nausea, vomiting and diarrhea - Purpura (a rash from destroyed blood cells leaking into the skin) - Acrocyanosis (discoloration of the extremities) - Abdominal pain - 25% of bubonic plaques progress septicemic plague Treatment for Plague - Quarantine the casualty for the first 48 hours - Maintain standard precautions for bubonic plague patients and droplet precautions for pneumonic plague patients - Streptomycin 30mg / kg / day IM in two divided doses for 10 -14 days - Doxycycline 200mg IV then 100mg IV BID, until clinically improved then 100mg PO BID for a total of 10-14 days - Vigorous fluid resuscitation Prevention - prophylactic vaccination series Viral Agents Smallpox - a systemic viral disease caused by the variola virus. Endemic smallpox was declared globally eradicated in 1980 by the World Health Organization (WHO). The only WHO-approved repositories of the variola virus are in the Centers for Disease Control and Prevention (CDC) in Atlanta, GA and in the CDCs counterpart, Vector, in Koltsovo, Russia. Causes of Smallpox - Contact with infected respiratory discharge - Contact with infectious bed linens or clothing of casualties - Contact with drainage from wound Signs and Symptoms of Smallpox - Sudden onset of nonspecific symptoms: Fever Headache Backache that lasts 2-3 days Vomiting Malaise - Two to three days after initial onset, a rash appears. It starts with face, hands and forearms, moves to the lower extremities and then to the trunk. Lesions will appear as minute macules, then papules, vesicles, pustules and finally scabs. Scabs form at 8 - 14 days and slough off at 14 - 28. - Casualty is infectious throughout the entire term of the disease until the scab separates and falls off. - All lesions occur simultaneously Treatment for Smallpox - Quarantine the casualty and maintain strict sterile procedures - Supportive care Prevention of Smallpox - Prophylaxis: Vaccination of vaccinia virus. Revaccination should be carried out every 10 years for personnel who are at risk of infection. - There are no routine immunizations of US forces for smallpox. When the threat indicates, senior leadership may direct vaccination of personnel. Biological Toxins Botulism - a biological toxin caused by the bacterium Clostridium botulinum. It is the most toxic substance to man. Due to its incredible potency and relative ease of manufacture, botulism toxin is considered a likely threat. Botulism acts as a neurotoxin. Causes of Botulism - Inhalation - Ingestion Signs and Symptoms of Botulism - Blurred vision - Dry mouth - Dysphagia (difficulty swallowing) - Diplopia (seeing double) - Muscular weakness - Symmetrical flaccid paralysis (Loss of tone and reflexes) - Respiratory arrest Treatment for Botulism - Rest - Oxygen, if available - Cricothyroidotomy, if needed - Mechanical ventilation - IV and IM administration of trivalent botulinum antitoxin (ABE) Ricin - a toxin made from the mash that is left over after processing Castor beans for oil. Castor bean processing is a worldwide activity; therefore, the raw materials for making ricin are readily available. The toxin may be either inhaled or ingested. Ricin acts directly on cells by inhibiting protein synthesis, which causes cellular death and tissue necrosis. Signs and Symptoms of Ricin Inhalation - Acute onset of fever - Respiratory Distress - Hypoxia - Cough - Malaise (discomfort, weakness, fatigue) - Myalgia (tenderness in the muscles) - Pulmonary edema within 18-24 hours - Death occurs within 36 to 72 hours Ingestion - Severe vomiting - Abdominal cramping - Diarrhea - Shock - Renal failure - Circulatory collapse Treatment for Ricin - An antitoxin is NOT available. - Give supportive care - Isolation is not required 3. FOUR PHASES OF DEFENSIVE MEASURES AGAINST BW AGENTS Pre-attack Phase of Biological Warfare - Train and inform personnel of possible agents. - Discourage rumors. - Practice good sanitation and hygiene. - Ensure immunizations are up to date. - Protect supplies and equipment. Attack Phase of Biological Warfare Signs of attack include: - Aircraft spraying or dropping objects. - Lobbing of low blast shells or bombs smoke or mist of unknown origin - Dead animals with no visible cause - Rapid increase of patients at sick call Defensive measures include: - Stop breathing and don protective mask. - Give the alarm. - Remain under cover, and move outside only after cloud has passed or ALL CLEAR is sounded. - Cover exposed skin. Post-Attack Phase of Biological Warfare CONTINUE to practice an increased level of good health, field sanitation and hygiene discipline. Keep wounds, cuts, and scratches clean by using soap, water and utilize available first aid. Don't consume local foods. Eat and drink only approved food and water. Do not bathe in lakes, ponds and streams. Do not touch animals, especially dead ones. Observe BW contamination markers. Decontamination Phase Designate an area for the decontamination station. Establish and operate the station. Provide personnel for monitoring teams. Post NATO Biological Warning Markers. A triangular shaped marker measuring 11" x 8" x 8" with blue background and red letters spelling "BIO". (See figure 1.) REFERENCE Medical Management of Biological Casualties, July 2000 Biological Agents Review 1. List the signs and symptoms of inhalation anthrax. When and where does the smallpox rash develop? Identify three facts about Botulism. 4. List three actions to avoid during the Post-Attack phase of biological warfare.     PAGE 1 3 -  PAGE 30 The key here is PRE, something you want to do BEFORE the attack! The key here is ATTACK, things that you would expect to see during an attack or what to do during the attack! The key here is POST, things to do AFTER the attack! Figure 1. NATO Biological Warning Marker COPQVWYZ[\ - 9 ] a c   > B K O R ʯ񢯕񕋁si[h Jh/OJQJ\aJh83OJQJaJh Jh9O[5>*CJaJh 5OJQJaJh$OJQJaJh Jh9O[OJQJaJhiI5>*OJQJaJh Jh9O[5>*OJQJaJh 55OJQJaJh JhMjO5OJQJaJh9O[5OJQJaJhX*hX*5CJ\aJh Jh9O[5OJQJaJ CPQ[\c R +   & Fxgd$  & Fxgd$  & Fxgd$ x^gdMjO  & Fxgd$ x^gdMjO$ I R !"a$gdMjO $^a$gdX*$ I R !"^a$gdX*F8t89R   $ ( g   B s t  % ) ` b w { ĶĬĞĔĶĬĞĔn!h Jh9O[5>*OJQJ\aJh$5OJQJaJh 5OJQJaJh$OJQJaJh Jh/OJQJ\aJh83OJQJaJh Jh9O[5OJQJaJh Jh9O[OJQJaJ h 5aJ h$aJh Jh/\aJ h83aJh Jh9O[5aJh Jh9O[aJ) no+`gdOB & Fhx^hgd(chx^h`gd(c  & Fxgd:gdOB & FgdS x^gdSx  & Fxgd$ *<Tkmno*+y{ϴϴσugZuSLSESZ h/h:>j h/h_X h/h9O[h/h9O[OJQJaJh/hJTOJQJ\aJh/h9O[OJQJ\aJhn^^h9O[>*OJQJ\aJ hOBhOBh9O[OJQJaJh Jh9O[6OJQJ]aJh Jh9O[OJQJaJh:5>*OJQJ\aJ!h Jh9O[5>*OJQJ\aJ!h Jh#.5>*OJQJ\aJh9O[5>*OJQJ\aJ)*;LOP@HLTW]hjkȻȻȻȭȠȻȭȓyyoeh#.OJQJaJh/O5OJQJaJh/h_XOJQJaJh/h:>jOJQJaJh/h(OJQJaJh/h*OJQJaJhn^^h9O[>*OJQJaJh/hJTOJQJaJh/h9O[OJQJaJhn^^h J>*OJQJaJhn^^h9O[>*OJQJ\aJh/h JOJQJaJ&;@LX^t  88^8gd:>j  88^8gdOB8^8gdOB^gdOBx^`gd(c ^`gdOB`gd:>j  *`gdOB *8x^8`gd(c *8^8`gdOBh`hgd:>j ^kj}^gd4 x^gd(c^gd4 TL^T`LgdYx 8x^8gd(c^gd's hx^hgdOB  & F xgd:  88^8gd:>j)*FIgijp}ЭРxk]OA4h/h1OJQJaJhn^^h1>*OJQJaJhn^^h9O[>*OJQJaJh/h1OJQJ\aJh/h:>jOJQJaJh/h83OJQJaJh/h:>jOJQJ\aJh/hJTOJQJaJh/h9O[OJQJaJ$hn^^h9O[6>*OJQJ\]aJhn^^h<>*OJQJ\aJhn^^h9O[>*OJQJ\aJh<5>*OJQJ\aJ!h Jh9O[5>*OJQJ\aJ"$1MTXq  z{}h/h`maJhn^^>*OJQJ]aJh/h1aJh/h_XOJQJaJh/hiVOJQJaJh/h83OJQJaJhn^^h1>*OJQJaJhn^^h9O[>*OJQJaJh/h9O[OJQJaJh/h1OJQJaJ4{BEr TL^T`LgdYx 8^8`gd4x^`gd(c ^`gd4 ^`gd4Lx^`LgdYx L^`LgdYx M^`MgdYx^gd4 x^gd(c L^`LgdYx  5ADDGFGHRUVtuv٤٤ٱٿzmh Jh9O[OJQJaJhn^^h<>*OJQJaJhn^^h1>*OJQJaJhn^^h# >*OJQJaJh/h83OJQJaJhn^^h9O[>*OJQJaJh/h<OJQJaJh/hYxOJQJaJh/h1OJQJaJh/h`mOJQJaJh/h9O[OJQJaJ&Guw1Bs5 i !$!N!Z!!Lx^`LgdYx^gd4TLx^T`LgdYx^gd4 8x^8gd(c x^gd:xgd:>j 8^8`gd4x^`gd(cvw}017BDru# ٿyll\Lh/h9O[OJQJ\]aJh/h<OJQJ\]aJh/h<OJQJaJh/h:>jOJQJaJhn^^h<>*OJQJaJhn^^h9O[>*OJQJaJh<OJQJaJ$h Jh9O[56OJQJ\]aJh Jh9O[OJQJaJh/hJTOJQJaJh/h9O[OJQJaJhn^^h9O[>*OJQJ\aJh:>jOJQJaJ# $ % + 4 7 h k q } ~ !!#!$!%!0!3!M!O!Y![!a!!!!!!!"","-"/"d"g"ࣕyiyh/hYxOJQJ\]aJhn^^h<>*OJQJaJhn^^h9O[>*OJQJaJh/h<6OJQJaJh/h9O[OJQJaJh/h8zOJQJ\]aJh/h<OJQJ\]aJh/h)IOJQJ\]aJh/h9O[OJQJ\]aJh/hiVOJQJ\]aJ&!!!"-"e"""" #6#h##!$$$$$$ hx^hgd:h^hgd48^8gd4 x^gd(c TL^T`LgdYx 8x^8gd(c^gd4 x^gd(c^gd4g""""""""""# #)#.#4#5#6#8#g#j######$#$8$vvi\i\i\i\Oi\hh4OJQJaJhh9O[OJQJaJhh<OJQJaJhn^^h<>*OJQJaJhn^^h# >*OJQJaJhn^^h9O[>*OJQJaJh4h9O[OJQJ\]aJh4h<OJQJ\]aJh/h<OJQJ\]aJh/h)IOJQJ\]aJh/h9O[OJQJ\]aJh/hOMOJQJ\]aJ8$j$k$$$$$$$$$$$$$$$$%+%%O&P&b&c&e&&&&&&پ̱٣̱tg]Oh^eh(c>*OJQJaJh<OJQJaJh<h9O[OJQJaJ!hh9O[6OJQJ\]aJh^eh<>*OJQJaJh^eh9O[>*OJQJ\aJhh:>jOJQJ\aJhhJTOJQJaJhn^^h9O[>*OJQJaJhh9O[OJQJaJhh<OJQJaJhh83OJQJaJhhs<OJQJaJ$P&c&&&&'>'D'M'j's'{'()4)K))))TLx^T`LgdYx TL^T`LgdYx^gdN x^gd(c^gdN 8x^8gd(c^gd4&&'''='>'C'D'L'M'_'`'i'j'r's'z'}'''(((((((((())3)4)=)A)J)K)ʽʰʰʰʰʰ󣖈zlh^eh>*OJQJaJh^eh# >*OJQJaJh^eh9O[>*OJQJaJhhOJQJaJhhOJQJaJhhNOJQJaJhhYxOJQJaJhh9O[OJQJaJh^eh<>*OJQJaJh^eh(c>*OJQJaJhh<OJQJaJ&K)M)))))))))B*E**********+4++++++++++, , ,,˽٭uhuhٽ[[hhR!OJQJaJhh1jtOJQJaJhh(OJQJaJhh9O[6OJQJ]aJhhJTOJQJaJhh9O[OJQJ\aJh^eh9O[>*OJQJ\aJh^eh>*OJQJaJh^eh(c>*OJQJaJhhOJQJaJhh9O[OJQJaJhh83OJQJaJ#)C***++ ,,7,H,T,y,,,,,--0-O-h- x^gd(c^gdN8^8gdN x^gd(c hx^hgd(cTLx^T`LgdYx TP^T`PgdYx,,&,3,6,7,9,G,H,J,S,T,V,_,y,{,,,,,,,,,,,,,,,------/-ɼwwwi\hh# OJQJaJh^eh# >*OJQJaJh )OJQJaJh# OJQJaJh Jh9O[OJQJaJhR!OJQJaJhh )OJQJaJhh9O[OJQJaJhhR!OJQJaJh^eh )>*OJQJaJh^eh>*OJQJaJh^eh9O[>*OJQJaJhhOJQJaJ$/-0-2-N-O-Q-g-h-j------//-/7/A/I/J/L/`/a/c/w/x/z///////////ټ󮠮ɠppppphh# OJQJ\]aJhh9O[OJQJ\]aJhhR!OJQJ\]aJh^eh# >*OJQJaJh^eh9O[>*OJQJaJhhJTOJQJaJh^eh9O[>*OJQJ\aJhh9O[OJQJaJhhR!OJQJaJhh# OJQJaJ%h---/7/J/a/x//////$0.0@0U0`0h0x00 x^gd(c  ^gdN  ^gdN 8x^8gd(c  ^gdN^gd# ^gdN//////0#0$0-0.000?0@0B0T0U0W0_0`0b0g0h0j0w0x0z00000000000000000000ತತtthhs<OJQJ\]aJhhYxOJQJ\]aJh^eh# 6>*OJQJaJh^eh# >*OJQJaJh^eh9O[>*OJQJaJhh9O[OJQJ\]aJhhR!OJQJ\]aJhh# OJQJ\]aJhh )OJQJ\]aJ-0000 1 1C1k11112&2J2d22222+3G3r3^gd:^gdN hx^hgdNx^`gd(c  ^gdN  8^8gdN000 1 1 111$1'1;1<1B1C1D1k1l1m1źnWG:-hh# OJQJaJhhR!OJQJaJh^eh9O[>*OJQJ\aJ,jh^eh:>*OJQJUaJnHtH!h# h9O[5>*OJQJ\aJh# 5>*OJQJ\aJh:5>*OJQJ\aJ!h Jh9O[5>*OJQJ\aJhN5>*OJQJ\aJh(cOJQJ\aJh:OJQJ\aJhNh:OJQJ\]aJhhR!OJQJ\]aJhh9O[OJQJ\]aJm111111111111111122222$2%2&2'2I2J2K2¸¸—vfVHhh:OJQJ\aJh^eh:>*OJQJ\aJh^eh9O[>*OJQJ\aJ'jh^eh-W>*OJQJU\aJh JhIeOJQJaJh:OJQJaJh:>jOJQJaJh Jh9O[OJQJaJh# OJQJaJhR!OJQJaJhh# OJQJaJhhR!OJQJaJhh:>jOJQJaJhh9O[OJQJaJK2b2c2d2e2g222222222222222223333*3+3E3F3H3J3p3q3r3s3u3ɻɻɓɻyl^ɻɻh^eh8/>*OJQJaJhh:OJQJaJhhR!OJQJaJhh8/OJQJaJhh:OJQJ\aJhh:>jOJQJaJhh9O[OJQJaJhhR!OJQJ\aJhh8/OJQJ\aJh^eh8/OJQJ\aJh^eOJQJ\aJh^eh8/>*OJQJ\aJ$u3333333333333333333 4 4 4344454<4=44ʼʼ攄vfYfLh Jh9O[OJQJaJh:5OJQJ\aJh Jh9O[5OJQJ\aJh^eh:>*OJQJaJh^eh9O[>*OJQJ\aJhh9O[OJQJ\aJhh8/OJQJaJhhR!OJQJaJhhR!OJQJ\aJhh8/OJQJ\aJhh:OJQJ\aJhh:>jOJQJaJhh9O[OJQJaJr3333 4445D5n55556)6Q6w666666666 x^gdMjOh^hgdN hx^hgdN x^gd(c^gdN444444444555B5C5D5l5m5n55555555555666'6(6)6O6P6Q6u6v6w6x666߼߼߼߼߼߼߼߼߼ukh(cOJQJaJjhJTOJQJUaJhh9O[OJQJaJh^eh:>*OJQJaJh^eh9O[>*OJQJ\aJjh6WUmHnHuh:>*OJQJaJjh:OJQJUaJh'#OJQJaJh:>jOJQJaJh Jh9O[OJQJaJhR!OJQJaJ*666666666787977777777E8F8G8I8J8L8M8O8~shshs]hsOGCGCGChajhaUh JhSQOJQJ\aJh6WOJQJ\aJhx35OJQJ\aJhSQOJQJ\aJh9O[OJQJ\aJh Jh9O[OJQJ\aJh Jh9O[5>*OJQJaJh'#5>*OJQJaJhR!5>*OJQJaJh#.5>*OJQJaJh:5>*OJQJaJh:h9O[>*OJQJaJh(cOJQJaJh Jh9O[OJQJaJ66797R77777777777777777777  & FxgdSQ  & FxgdiI x^gdSQ $x^a$gdMjO x^gdMjO7777F8H8I8K8L8N8O8Q8R8]8^8_8o8q8r8s8t888$9 $^a$gd83$a$ j&#$gdK0&`#$ x^gdSQO8P8R8S8Y8Z8[8\8]8_8`8c8d8j8k8m8n8o8q8s8t888888"9$9%95999;9X9Z9[99999ͤ󘔘~zvhh JhSQOJQJ\aJhRmh(chh(cCJOJQJh:5CJaJh:h:h:5CJaJhuYOJQJh^e0JmHnHuhM07hK00JjhM07hK00JUhM07huY0JhM07hb0JhuY huY0JjhuY0JUhajhaU&$9%9Z9[999999 x^gdSQ^ $x^a$gd(c $^a$gdR!<00&PP:pBvh/ =!"#$% n.rXlOXc2PNG  IHDR9sRGBqIDATx^ ]eu/t!7 ) ÌV[-" jQk_m_'_ֶjjQ BBBHI !dNnn{ssΞw!bx9}}[o[kYixczXpn?H3#ӌ7gYjFfrFgk3X%MSM_^J5˲l6M_MK7 #ITp $o3gک$ .D\'VGB.|7.:af6u'}⍩`Vop0"1ߓW`x\Y<~! ]kDBGq/KP b|sEQӰy{xu5D<]ƯFz:wb:Drq1 -''9h8^J8qAP񕄇/ыFb28׆KSSj)((lZui)ũb(Q&_ynJRJ8̱[*lPgcҦ.Nr1G7Y*JYȩpX59V9]ECs$$u"D/rQU1Mճ!T zKjF լ nMd pQ]Ռ[ >uwb'EGԧ _dyc N*`#! Qa08'u >oTͲ4.OySqVQR<Ru`90ux.[$jDžԢ {̈psR ҌTѲu*!iL8vmc(0!;Zhmۖ7w}ς|wnXٲuvrҹv\ (1d%S, *B,.|>80~;OpvÒQ)ʣbjCڬsd8xy^c%DZf"I&_A'8^_S.,:/,ŵW_urVdQsVєT GD-ߧ0.q-Olǩ2Z9) *jm(qW8- 12) e1 Bf5u)ŔA㏭ *zp ρH= 0XxǀG(ҰJŃMy4ҫ8?OMc'8ع,Yn2,FkݨgVF`g>aM~x|c+kSM}ƉavMm+)!NpȕzѯX!p7bh;j!KbrZxeCyZ"S8'+NO% _k*_WPAИPd `6tըblįt`O*&hXtl U3䘏r~d%x9cdT6a%`ճsCi}5DEO,04P P"2JXiBQxɽ=[-3mW͘9S'~P_˟xn鲧 5~)< yrRk7pTNZ=W Bo$NF $v:5^nAuZ:YT8#YcA``((T ؘ;'~ѹq ;4(AMiw^*_&ؠfLbeՁM$m * +4EE)rc4q/H^!O'>gxIa r)1HO 4=oaqO?׵S PK fCBXVbNu˅,wi'N' zwyo׻^6?Wﵴ['`'hw+t#feHf0epF 9ܪ"|GMAAX/цqO]ہ~NN(kʴ-vii.Q[ifhYְ/ٚ=)uX^o,wwV Tc!^-zh%Ut sR14xU D%PpRE|n84bp({b hԌ18'opȱeP}֨( ],H96= D%Ȼ9e4NO  :#Dѫ{X\i:`v\{['zɻ~Pi~&~j=ӻ.q\R->`7PbIL Ђ$걶 SRB"QZWv泈DR#:4P\:3:vNd){ 8WcX!s-*lM, D\`G*:U OXt{R,ENa3hھt)\8m4;G=' ))لZp"c5=egVNv5)3@rci.n@ӃO'%kne4/V}Fqau¾ήmN(sE35Ԉe~L?o+0nf~PsZm k3Ac j!6 34Gj/17ub͖K^͸N\j)YRS96K՜=; Nʳ.e N_/k|ՋW=oys򔁾 ޴̆vW=pE=Tbͧ[,71Lq׆QrdFaUQ7]]KT많j~W`h6g:#}y IT7V N@'~ߍ:@g!_;nq>t}5VYy>HLga.>,%FI4iU@\'։V0BQ>I 7xA"OJ ސ㩔*< KP \Uat JRq$ yvJ94vxn1ܙ>T_߾q7^3窎oi4M7l{Mhc@ܚ֯zHPoK̢1/b P,WOjU %FNrCnV Ll!!,Afas; ='{׍:T],J0vؼ ݦH3c׊ 5 :FY9󆳶us3挞2'xQAv,Th4{Oy+ظf?3G+N @HLp]zAlY/PWak[h  g8N،P70p{-L[08ka5X ʮO4G`q,R m|P5 v<ΣT Nc|HX BuO8jL) \/31cL> <^еFy۔ϟqO~CEl}Ϝ{Ym?ؽuwyo_:-WpP$ ܓ_fHSG6 \pR б=YJ!!p\b5yx-!¨`;$a89jnob1.J6C͛ 3lk]wu`E\T'$5j6mu3=nۿؼii^.F5Fwr?e3u\ 1}^2D#4K]܋bzE>u\YD)}=PԺQhkp˘m>J'mڣ룭]Y>K΍hSJȚ#FR..T@4 SWh&DU}BڊSKc$NP !8LmXeV8r#ljp͋O4gn2䈳^UM۾uHwV3衠w[qq\@bhr*{6WQBi0_ڱ82"e 0_y9\2Ft +ح0MZƮ"rYx V=$ți'Tl`&" KndqjYSu>km;&c64 iV&W::{~M8\nY&mN"65yIyZ0_)]k_e8`9.=h(⅋PA7\i1#+ݵ/JH"D MX+u/4a=muυs?_&/'g]^lv<a=4! `y ]% ĺe򍘈Bׅx A}SqtKp☓Bm hTZ\sp3pu VWD^ڝARJdH5{2P*Da_d,͢6)6=G[Ɖ)8V:>q"f+=2w4<:a:';E`OY\;pOrTWfa_%OgdgEkaS@ ~dIp-ǝ HoS  E|n@tqYl<1畢 QǦ w,z.4f>󔎗%D AjJx(>aEѤrqOLFn^¼3?}/ /vk}};luoOzEpeE[n\  QЯ"2cN]cp7=~\(4*7T\\#">< uRL"iuh\n#-X` =+v]US||>k~hl,Ej?yM,Ax<aMp!mtquUwόiQ녥gͼh}.Ւ-)5 ps}uKn7Dij2lÈmh$=˴t;yn>݌N-5`NpϜjIjiN[p#]nL8S 1^ Js DRp38.WY O@,6!gfNVؽ,7w2Xsκgt߿whZ)MKB3BYRW)ʰShD,XC=e{ 0]ML`<=wwANJDHF<1\ճi9Xi=;N2b~fAdEi]0uF%tqh¬3ܺ! n!jвA8osA"S#(kh[M%_|, [j ?|*l.  " {KtaDL V {WGΙz_}0e~ßx׻/8kZS?>*`M oJ|1"j4+akI}pz]1(W&Ҹ"fcG.a3׎^Oy+r 7"@cP3+3 + ;`δ`# z+eOwpvj ˢFx3d]6MiQTdhف"bj^ -;utD]LH[YИ~:,F\vXeFOPX`MoY?ᬕUNȴosfw{ }Np9JV8cM_cxR*$(B1u^t,bT/9j7[bA &d~3{dTϹh]wLX ~׾gLi;w`#Jalg' :3񬊙YZx@`a1\OS@x r58'I /,JPЅzzTqhiژܦ,FRA=-'qO!M(T7oړ:28)pxЏ{B,brd*F0HQ*N2 [Tw8F\K׮8'_K|PO:4q7bvMW8wcZIL=gbzq-iF`{˜\u7bP<yʩ |5R"muW2@ֵҋ3Q*n<&zIiv+LC7Wҝpld>9\l}П|[Oi3k9w  ǏmYcΊ1;Yzc*(>ńJf0ClE-Џ'!HQʎԈ V:^Ld1! v=H(%B JsB4H椎g)p7OAŌGSܞd}[7MBA 8uLmOxZ\v mg"#a6\,N9)LUy-o@U~ch5N t7yFSh㏧ʎr{x2etҧG5jl:PA^Qp&^$C&1"aCNˡMi_d`pS?|Q>ȣk|}7}Ϭ S|bq80Tr`D~UTR+9PhQ$}l {ƴ꫋JDѨ%@6bY !ȳBa IRO)mV43'?b{5JEs"lLl5,)8TwI647#v@I2}osPg("8 pDTq{È9vj @B,!N\ ЋF#zʖ,l2zGvHMGOV4Iph$+BhJAG[ 8'V,*aU⾐ g*"'ŀ(EB5%$DH{CݻWQ=I+eNYpb"}E@dA`SlL/iOFXjL %vL"7 M rhe{T/MƩ, X$N "nF5a2ܐ-!PLG0@Gptأ Ǽ5(H)9nhD$&^`Yy=ͅntCV).ߔk[ y],cZʻQX۾Mgzo&2.O s` -uF N )bU=aÄ塼CG&f9W fԪ0IL]>0y1t3^a`\cO!"*?\?fB?p$IIJ|c^8[*t8B͇ŝ<oj̸m'9a>w?yzzE ~oo̖\wW<% YOcdn0hU ?I0=dh(P[Sʟ >@YU|PdB)2/ f:t圑̬Hnmxv 鞫95S<iD5!sW#{ s Zg@ YC .gAR=Ln|T.EϲQp. UE$@$q,[B8 =$F"m 0|ṕhHQ7fscStź4_Ub:"aYp^3E\b5e~t#h:$=c'8ӟ yl׸\35V=AܓGpɜL}E }ITŢ+11AJ!eE"8\s`)'Z>D&N-Ӫ«xan"M<4̆JEktőhXϽxdX95LRlc|/@Pa 4'ёwdQd/$ |bQ-~Lz_T5H!C%Fa^k,*Cд(Kx,cRJȳ c$Dыy"zj{.H7G܍Ƒgϙ;>f2-Kؽno{gDtX'䀪P $CRP '^ Yb?xURjx9XF#KG+˓iMlE^јh5ogέxK#}L/ @ɠW*I(sض I=x[p=.vpQ(%]iI(ƅkiyH\I\NN*@P s+APD ;7b1ڑCumBV6JsA0R )z^nza]]n۰SQ̖L ^>w zlݗpocBuT'Xᶡ]kvl9 4xP p7Wb)G>Y%~f e#BC!b_2lIm0$% J8D.ʴeyc z5N& ISװY$l6Uy3PT1$,Im,Ih~, 3Du'%" Ja [p#4[fiGݻ.8?=D=+ sμJxhz;&V[!H5M K&T!6eMm}I.){ JHTkE`ڀT$c %vHr'׌sHדόtp1pDǕloʮS̷D_;Z;쌫S|zN|,v8A۹MmaanN4V\TiZJ80 SD*К@>{5'hoRy@%h2G*|x0V`63|8E>{ʖs8Q ;VTwr7N$(䊙9.*ZpNIn $9We.ƌyqr [O\eSA\n4v.鿻˴Z|dk9lvL&MMoW.h⾍(>C 3O6b {T#f'v!b?LӇH90p;n(R3"H p hjnF'ȠfZ% &IUDhlSn _GQ,tW8]0.@F2T1>,Z$W hX[T0(S;2vJrwןܿ{3*b߻ߜk~<ڿ?fkQyFThLiCC 55 sQ>0"'PjitQ{aXԞ"X}aTr'>dh1@+B(ccUML?@Ytw0)FN{s^2A@}%];V}[e6GT&V ZةV0 K tXlt"/ȬaTA9DC24wj9TCXhoRldJM\8v#5_B5f4Pޔ_EyJ0” }0Zgv.en8Y5@ J:wkA_?CI agyD~artA' 1؍Xa 6 qCn~WR`nͲF#=ԎP~(“ȴK!#VlbaZeO,nGa:LŚ:?wvE§M=ₗ09?p@0!⇐/bB|խi%?YO$  _j _ bXPy'&(fx.5l@e`\NT+h_IMmH"7V p0!iìLjC@3*^,[h옾yw@ipZm[c6fbzEQ`Z,&]zP8]Jب0})m3!rɈUXxe4diC!fNMUNc֘ Ua0~ґicكj{W]OS:WWq[7ydZ}},TzPXRJG 2iġ&՛N_7EjrLAԾR Dx4Φ  XEmTfn%8R baT~D!R(,d?FuqmW5+1x{C~~'-aU5cQ.iZ6g`$Nb%ɮ K8Q2%xaߖV`?lFAܦ4iF[fR6=S̓dΑUަPC,$v.YLFX=^T>$^n*|eϕŀS*pQIآܴB>uQA֏:gbYMdmA-JAX^V%PL Il +EIm3MuMO8uCĭ4݉ D0/wZ4%d@>K[GT,@!%m47?#7ȶG|OwJ|۟† 0#Sb>ܦLXk( #-@px 5 jHR.ኀWJ?C$'PTF 烰a: "p`y3wV$ӟUG\P$r Mk m`UM+LG6?1wp{K30{JwLyݴceU W-m~楅BcGRd!z%ř$̷j^+ sҬ>0_XdB&=[b[S>Z}fkzf=V'FC V#2:tЦʃt,yfM)_u2k>cE.+Na p@ƽXϝ2օ+.o2r) C*<t ]jI8?M.`?}{2,>~ߺ8݇-5"OK^ z7.>|'}_~zׯwU};^ żTe|5l/gϰ!^@ؘdv tf> Wt@;<*@GhQ ;ڜG֮Dۓ=o"}a=IA'vD(؟&mGdյաŁ~rTK 77ipޠuثEPE"|`FB]\dlJ33-2&,8 kLj/Ľ;藇zMaۉkK3l GEFY `A-!eܫYb[C{-]==4'Ci%-]Hg!PU; UP:v!Ep>i[{/W_O=oN*\~s$biT5o зS@t&$ChP'=c2}`bf/W!X0.xtmfG<7(ڃ!{A`@\ Z._-9'['Z͍88P~zp<.+ K#zlYة SN}k&0:8(ȭŅ46UmV4OJԚikBvr EIt^:Q?| TVF0+m-Z[[+ֶ=Ey,b{)# sjщ5B nPvRv ]T};Z< _3>T_GbğO~x<,봉%au`ҡDvEevi23|lzԸrDwLH< tLB$P'*8i CQ#BP, RSEGyInU2 n,K\ lT@.#4E|&hMxQIpt F!?]ǒ]h&=,{)ȰP8t "h^᳆{%Q@ڃÄ |5DW;F)wmq^;חX,Yvvk)gW^UAQI~@4b'H`eAoA8!Nz B9~@yI!wЌ^ AO.هXghO #Nvy( *,Ԇ :Sו }<(8gZգj㠦JƜ0+' G%pNw)棫Q@+rR_X\^ĝ&䉬_ h-{tY_Qt8x y݉5CSr5[^?L@$]4N]ǠT\% Zve1;!FEI.xj"RHb.(A# Uc2(pdmPnjRG\9V0aX@F`2C %++j R(v >}(orףּ[B$]=}%-m&۫)N1gY=PΣת\:6tJ7>Q2JjE > (\Z 7 %Er=t``/}=ZSs|$]`PQYX[i"Z{,3>֯R8ءdp@ V6,gkE;A5^di޻zI zDs y X;v(T_Qoy$cU܆lM՚SˌB?)Z #وy LLJy8ў_̙ܽ/~Hukr8gICdXlȠ[hhhsYn}Pi+Q Ei)[N<RԔEEH*03Qp&<<'IYZG)u Iq1pC@cpѮ8cQ?sY69]n³u%z#qa`ABZvhpf_Lٯ@ϝw}+Jw--u:z9*#[\c8JnȂ4CfU^a*e)%FP) D:pAHI T _BH|uw~T1WlѰ:p)0 0ڈ AcOt}s'~2crֹ[G<Ƴ?PvS*e\1<[)-te ]_tkjL#K&"dCgӸBLc B !q EsVBPqatЯ$g({ ýBZb%6fp@JŰ1%]W 9jyʠ٤6נz ilDZdz{O{M#!x2T~|M-ԀZӠ6Zde##߉SA`Bw20̒: '"۽pF7@~KnCߑZXIY础Dy$%J9vp*!Hk v倱c'~8y|`7b;>gΕ{v/w %pWMNcrP9 >2*a`CtHL$K(ݫ\ (N$ x}C$X5-U]G9#WQ5EdW >ua(3lĶh2~}d7W=5/hkVj-xD(*#O KQֻ/u_G)_Ob:Kx4s뗡u8-i4d{hJd=vVj$o |h9YPlV 7j@۱4' ܋PvrwLΓhVJkeOg{hn[4~9kajDp[2P>債b%'Oq(܎>Oܹo۵qGڻ9=د&م lZ/j  DBˈˀ s Qxl 4(# %2٩>4ΌnCI'E86AFx.%]ڢ;E,Zo^) D#lA`6")غ?2k5vYƶ<3L7_/O{́ώM5]4X_SQ؞Y]pS=ګZ!%xԑd(V UȆtv 1M-@_B6<m=VA-J|4]Q` F4vWKqg+<>#譖QP<"9N9lo[t͞z~my㇯~ّǥXa,|_j~n¤Scb)H#f0+63YXC gbr PPf`@sTgGYek#LOxiJ#Uq96k"&IN-Z,:ML q*"$ 'iY%ȅ&Č?ح%}INPaR72 "SR E+~{;_m;h(9ARxaFqV$S;r9pSx,2\(ge#UI>)yh#3qꡑrQ@!c0t镮ApMQZ,^XNs:lXڿ'_~ł9.rFj{[wd`o&FJ5$C˫ / $s"TJ+@hRE$OƦP?/jc{a(Yv,|/J)lEx&\% d?0+7*9+ĩ ؄dڹbL:+κCuGgsQoZ:kj84VÄtiÂ@$()c)}*@eqWEx!hL}>Uت#pVn)p"UN5*%̮Uo?pd8: % ޲w}Pڶf8`ǔϱsзYB,AؑIy:>W-}kMT Nxv^Md0:%PyrɅx8cro~8ü7Xϝ 0 84=/*v ycSb&gGW-=_^CQʇ‘xpG<_n{nSPހbM>]=8ڴj[N0(-,\9iQٿU]s)}"hyl΄~j%KԆ{O6w?~| S;d3Xn| ,c;#;eYSAp _W S"4`1Bd:ݬަV|%{Gހأ.oXΟžO%xǪNcky`1# Nْps 8h_QAKLJ*F|!Kfm }4u]9|w<Fks*WVn{imtt#IqI~P.!СA9bJ !i >" W>DŒSTЖMRVPW0]x_LsDhV&CbfWQ!yk/??% .Ϲzҽw؞OrT=; rQ$|R/EyW("_ ݾOnݏ^?vDqkL̜yg_]cjr0 QWJ.6@B >%|R/uIg:=]sߑ {E1CϾ0vn9i j͓"ǂCtZI(n5AR-psA a6 6QEh[XAѱֆ}ps x@p4zgj?G_87֛oWFDbM=Kغٝ7s$ɣP? a]f.HA@kT H+(To@%y%")YM!= QxQ @AE5tiFg8ٰlzJg_}ӭrq\%֘3κ >2u(ߘw.K.D^  A,ΛCBV@hQ!,D&TQ%cQA}u&+H[s=3۽Ok=Ӊ5-ȳ/J=[ٴR;4A Ԫi WbXy$+ WhMQ:H9 Vg9Ax(1pwȌ 4*"Ւv 7;0y r4ۯ7/!/Ug9/ {mҳ|Cѕ+Ye9ktZJzrRL#Bu;PE5ye}W&:0<gN+$ ֠62@bBmV)[큯׭h7wǵum6οN*۟]osn+8ۀ\@T-@Z*Ez*K'7RpEQ-+R.ž,T`a$(rʝT{U#duidjQC֖=|ǭ+sK*{7ٿkh1J]|R|GOHO_OU]tae(i*U.裸%xS |&%TA: G<3B<~k n7}2f Ypӳ[2gkE\̦ej@ TNhtb s `#GzF YO ZAyq 4rF>`!&h<#U~хErͥ;o\`gN/%Oܭty`&aB ܘI 4T.J󯨗JUzU(|M7xP$g.X:P=β@Kڜ{;Wlq- &q g_O=߽CM*Z8hC85P  YJp`|" 夡 SJ)F SjYW=>XFf83L mwDy(w]Ɏoڛoӿx/sw[pfĤ5M،L{3q5:?_T;=P"rXwX5 Pp\`?G1ꝲZ#)^ *=˟\]{㾼_ͼ<3ĤԨE$S-RWD'zUM$ڐ:XEA5rf@,H|q~92./7:{q_ O<9ܿhj/4ٌVC}zY W[V"tgVb6Ũ7K/}ےNΌ\oFr( "!$~Q~ }G>ɸX]҃w~bYᄏG0j%ǟB2B ߽rТ7teȦGK_ב[o/ (e .z H1eSX(V~eAa2·`V|4yzdx-zs8yxck4cu7y>O>ۼɓ#21] ԶQ_Y_A.j?FPXm=lxSYή%K|C7z8(j\r'iz{ Z>$bWӒy@4q̡F/ÏvQ4nB7dV|+-s~jAя^ whN'Zq$$z /P@9 LŵL8vy:E?4L ;/74wϊ|s\_umս`EU3@&3?\̩M3HQCOm;=ӝJ'ȱ͚bi?gnͷi*|^w? WfLr(i>6#8@k M䋻 1A XQa| ?kn›>62o]vNi#vP- RA`6x+4 G>töem{u2}lcq~ O?s}94N7JmLzrM;fڳƞ'{Fg{{>p38~gYЗ9ѥɻŬʐ -1=k}}ݍ|=fzT'G5lKwVnMOĝSAD|Ti5 |h]6lοdݷ~a:Ɠ0 9wy͋ӷcMvEt0Bl`מ Hq>30{5FTk?plm,8ݏ"" Wwϧã׾w?› Ւ[%9ה.6mPӎcw?ϾZ~ӟw\_Eo_b;IؒmY7?O8b*.N}{ؚ)gO8gn}73UgW]n=Oxmoӟ~7֯owY^KeUn~mY[5؛2b7?/HxtVrIENDB`@@@ Normal ^_HmH sH tH \@\  Heading 2$<@& 56CJOJQJ\]^JaJDA@D Default Paragraph FontViV  Table Normal :V 44 la (k(No List O bulletn & Fd>T vCJOJQJkHDOD titledCJOJQJkHROR Default TextdCJOJQJkH4 @"4 Footer  !.)@1. Page Number4@B4 Header  !XC@RX Body Text Indent1^`1 CJOJQJTR@bT Body Text Indent 2h^h`CJ6U@q6 Hyperlink >*B*phFV@F FollowedHyperlink >*B* phH@H : Balloon TextCJOJQJ^JaJLOL: Char CharCJOJQJ^JaJmHnHuB1B1CPQ[\cR+no+   ; @LX^kj}{BEGuw1Bs5i$NZ-e 6h!Pc>DMjs{ !4!K!!!!C"""## $$7$H$T$y$$$$$%%0%O%h%%%'7'J'a'x''''''$(.(@(U(`(h(x((((( ) )C)k))))*&*J*d*****++G+r++++ ,4,-D-n----.).Q.w........../9/R///////////////////////F0H0I0K0L0N0O0Q0R0]0^0_0o0q0r0s0t000$1%1Z1[11111000000000 00 0 0 0 0 00000000000000 0000000000000000000000 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000 0000000 00000000000~0000~0000~0000~00@000~00~@0@0@000000000000I000000 0 CF0s0t011@00eH00 00-00' ---0R v# g"8$&K),/-/0m1K2u346O89 "#&')+,./124579:;<>?B ^!$)h-0r367$99!$%(*-0368=@AC9 $'0!! /Xb$/7W?Oe( 5Okb$XlOXc26r>@V(  t  3 ԔS"`   S LԔ. SSU UU USS"`   S LԔ. SSnU UnU USS"` n  3 C"? ^  C ABIO"`B S  ?C)&*,-w.1q%tq%@$]@$ Tif't یb܌Ծ݌*ތߌ#)<) CCH <<F1 GOO  DLL1 9*urn:schemas-microsoft-com:office:smarttagsStateB*urn:schemas-microsoft-com:office:smarttagscountry-region9 *urn:schemas-microsoft-com:office:smarttagsplace=*urn:schemas-microsoft-com:office:smarttags PlaceName= *urn:schemas-microsoft-com:office:smarttags PlaceType8*urn:schemas-microsoft-com:office:smarttagsCity    X]^hzU_V$_${$$2%C%''F0F0H0H0I0I0K0L0N0O0Q0R0s0t01)**x..F0F0H0H0I0I0K0L0N0O0Q0R0s0t0[1d1133333>{%+O)O)b*c*++4,4,,,..9/9///E0F0F0H0H0I0I0K0L0N0O0Q0R0_0`0c0n0q0s0t000#1#1Y1Y1[111F0F0H0H0I0I0K0L0N0O0Q0R0s0t0143/b\G Vb. _+hU:J5dGc\z@rb4]: ) x<~XoS`,VE,h6uQgF2j(.dx))rZ6 AXB*DP CG+0NGPKOHp[JYF%7IfK`, h(L @O()P@0f SdγK T*Ud_%V'B e[Z.5;\Ln_t<0 atob\g|*G-e@)gB3A-hlH >i[flmLM qfwrЕ:_t. i >uc {8eR|,J3US@h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.&h^`56;<B*CJo(phhH."^`56;CJOJQJo(hH.88^8`56OJQJo(hH()^`56o(hH()^`56>*o(hH()pp^p`>*o(hH.    ^ `o(hH. @ @ ^@ `o(hH.   ^ `o(hH.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`OJQJo(hHh ^ `OJQJ^Jo(hHoh ^ `OJQJo(hHhx^x`OJQJo(hHhH^H`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hH&h^`56;<B*CJo(phhH."^`56;CJOJQJo(hH.88^8`56OJQJo(hH()^`56o(hH()^`56>*o(hH()pp^p`>*o(hH.    ^ `o(hH. @ @ ^@ `o(hH.   ^ `o(hH.h8^8`OJQJo(hHh^`OJQJ^Jo(hHoh ^ `OJQJo(hHh ^ `OJQJo(hHhx^x`OJQJ^Jo(hHohH^H`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.&h^`56;<B*CJo(phhH."^`56;CJOJQJo(hH.88^8`56OJQJo(hH()^`56o(hH()^`56>*o(hH()pp^p`>*o(hH.    ^ `o(hH. @ @ ^@ `o(hH.   ^ `o(hH.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.hh^h`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(.pp^p`>*o(.  ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.hh^h`o(.^`o(.88^8`o(()^`o(()^`>*o(.pp^p`>*o(.  ^ `o(.@ @ ^@ `o(.  ^ `o((1)h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.&h^`56;<B*CJo(phhH."^`56;CJOJQJo(hH.88^8`56OJQJo(hH()^`56o(hH()^`56>*o(hH()pp^p`>*o(hH.    ^ `o(hH. @ @ ^@ `o(hH.   ^ `o(hH.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`56;<B*CJo(ph.^`56;CJOJQJo(.88^8`56OJQJo(() ^`56o(() ^`56>*o(()pp^p`>*o(.   ^ `o(.@ @ ^@ `o(.  ^ `o(.4:_tOH{P Cwr >u3$2(4f Ss3ilmb. US) x4]*G-e+hUdGB0 a@OF2j(JobJ);am0 e[VE)PK TeR|-h\zg7IfKJ_%VoS;%<;6 AAy0*Iq> h(L44                  S&PHmlOm8/y RB Nf N<X[z#.:SQ'skh R!(U( )/n01x35/O5d6M07:=zC11F)IiI JmDMMjODTJTZTiV-W6Wk^WuYFY~Z9O[n^^beIe^e+vgBvh:>j`m4puBp1jtv||7}L}eN(* 5K0$s<H[ 4_X4o|KZ?xVxYxOB# 83*=E:OMa!6"'#:8z DX*/d=S(cRmv~a@\\mcuscljnps02v\CLJN-BLM104-FL1-RMS3A-X6350DPNe03:winspoolXerox Phaser 6350DP PS\\mcuscljnps02v\CLJN-BLM104-FL S odXXLetterPRIV0''''\KhCgoGRSMTJXerox Phaser 6350DP PSResolution600dpiPageSizeLetterPageRegionLeadingEdgeInputSlot*UseFormTrayTableDuplexNoneOutputModeAutomaticXRXColorAutomaticXRXGraylineAutomaticXRXLightnessLightness_0XRXSaturationSaturation_0XRXContrastContrast_0XRXCyanRedCyanRed_0XRXMagentaGreenMagentaGreen_0XRXYellowBlueYellowBlue_0XRXApplyToCMYKFalseMediaTypeAutoSelectCollateTrueXRXMismatchPromptTypeMismatchXRXSlipSheetSourceTray1SlipsheetNoneXRXCoverPageSourceTray1XRXCoverPageNoneXRXImageSmoothingFalseXRXJobTypeNormalXRXJobNameSetXRXJobPasswordSetXORX\\mcuscljnps02v\CLJN-BLM104-FL1-RMS3A-X6350DPWaterMarkHelveticȁ5x,)\\mcuscljnps02v\CLJN-BLM104-FL S odXXLetterPRIV0''''\KhCgoGRSMTJXerox Phaser 6350DP PSResolution600dpiPageSizeLetterPageRegionLeadingEdgeInputSlot*UseFormTrayTableDuplexNoneOutputModeAutomaticXRXColorAutomaticXRXGraylineAutomaticXRXLightnessLightness_0XRXSaturationSaturation_0XRXContrastContrast_0XRXCyanRedCyanRed_0XRXMagentaGreenMagentaGreen_0XRXYellowBlueYellowBlue_0XRXApplyToCMYKFalseMediaTypeAutoSelectCollateTrueXRXMismatchPromptTypeMismatchXRXSlipSheetSourceTray1SlipsheetNoneXRXCoverPageSourceTray1XRXCoverPageNoneXRXImageSmoothingFalseXRXJobTypeNormalXRXJobNameSetXRXJobPasswordSetXORX\\mcuscljnps02v\CLJN-BLM104-FL1-RMS3A-X6350DPWaterMarkHelveticȁ5x,)G/G/{G/G/1P@UnknownGz Times New Roman5Symbol3& z Arial7Tms Rmn5& zaTahoma?5 z Courier New;Wingdings";jf{,4)W4)W!4d.0.0 2QHX ?[z2.BIOLOGICAL WARFARE DEFENSEFMSSkevin.r.jones14                           ! " # $ % & ' ( ) * + , - . / 0 1 2 3 Oh+'0  8 D P \hpxBIOLOGICAL WARFARE DEFENSEFMSSNormalkevin.r.jones144Microsoft Office Word@@Z@R@$h4)System AccountSystem AccountDocumentLibraryFormDocumentLibraryFormDocumentLibraryFormF23340F18" ma:contentTypeVersion="1" ing feature." ma:contentTypeScope="" ma:versionID="b22a ?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}      !"#$%&'Root Entry F@}\˺O1Table~>WordDocumenttSummaryInformation(DocumentSummaryInformation8CompObjqMsoDataStore@}\˺O@}\˺OIOOQURJEUFA==2 @}\˺O@}\˺O   FMicrosoft Office Word Document MSWordDocWord.Document.89q repoint/v3/contenttype/forms">DocumentLibraryFItem  PropertiesQOU4G1SYG3D==2 @}\˺O@}\˺OItem  Properties 23WKLMBI1OO3U4A==2@}\˺O@}\˺OItem %Propertiesquence> This value indicates the number of saves or revisions. The application is responsible for updating this value after each revision. a/core-properties" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:odoc="http://schemas.microsoft.com/office/internal/2005/internalDocumentation"> This value indicates the number of saves or revisions. The application is responsible for updating this value after each revision.  usmcW.0' BIOLOGICAL WARFARE DEFENSE TitleP\ht !"#$%&('4(@)L*X+d,p-|./0123456789(:4;@<L=X>d?p@|ABCDEFGHIJKL(M4N@OLPXOPublishingContactPhoto1Photo6 RelatedLink2PublishingPageContent StoryDatePOCPhoneNumber StoryPromotionUnitLevel4 Photo11 POC Email PublishingRollupImage ArticleStartDatePageContentText POCAddressArticleByLine RelatedLink5PublishingContactEmailContentColumn3ContentFeatured2Photo4StoryPromotionUnitLevel2Photo9Photo14 xd_SignaturePublishingPageImage SummaryLinks Dateline xd_ProgIDPublishingStartDateSummaryLinks2 StoryPromotionSectionHome! RelatedLink8"+PublishingVariationRelationshipLinkFieldID#ContentColumn1$StoryPromotionUnitLevel5%Photo7&Photo12' RelatedLink3(RelatedLink10) _SourceUrl*_SharedFileIndex+Photo2,HeaderStyleDefinitions-7display_urn:schemas-microsoft-com:office:office#Editor. TemplateUrl/ Audience0ContentFeatured31Photo52StoryPromotionUnitLevel33Photo104Photo155 RelatedLink16 RelatedLink67PublishingImageCaption8ContentHighlights9StoryPromotionHomePageOrder:POC;ContentColumn2<ContentCategory1=Photo8>Photo13? RelatedLink4@ RelatedLink9A Unit_Lookup2BPublishingExpirationDateCPublishingContactPictureDPublishingVariationGroupIDEContentFeatured1FPhoto3G RedirectURLHStoryPromotionHomePageIStoryPromotionUnitLevel1J7display_urn:schemas-microsoft-com:office:office#AuthorKTagsLPublishingContactNameMUnitN CommentsOPublishingPageLayoutP RelatedLink7